Can a patient eSign the report release?

Yes, electronic consent can be valid if intent, consent, signer attribution, and record retention requirements are met per 15 U.S.C. §7001 and applicable state law; provide a consumer disclosure when required.

Is HIPAA compliance required for eSignature?

Yes for protected health information. Obtain a Business Associate Agreement with the eSignature vendor, enforce access controls, and ensure encryption and audit logging to meet HIPAA obligations (45 CFR §164.504(e)).

What if the report contains an error?

Correct the report promptly, document the reason for amendment and retain the original with an audit trail; reissue the corrected report to all prior recipients and record the correction process.

Are notarization or witnesses necessary?

Typically no for routine clinical reports. Notarization or witnesses may be required for legal uses, certified copies, or jurisdictional evidentiary needs; consult counsel for forensic or court matters.

How to confirm signer identity remotely?

Use multi‑factor authentication, knowledge‑based questions, or enterprise SSO; stronger identity proofing reduces dispute risk and supports auditability during review.

How long must signed reports be kept?

Follow HIPAA retention of 6 years from creation or last effective date (45 CFR §164.530(j)) and retain billing records for at least 3 years per IRS rules (IRC §6501(a)); check state rules for longer requirements.

Electronic Signature
Templates
Miscellaneous
Genetic Testing Report

Genetic Testing Report

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

GENETIC TESTING REPORT

RECITALS

WHEREAS, Client Name: (the "Client") has requested genetic testing services; and

WHEREAS, Laboratory Name: (the "Laboratory") is duly qualified to perform the requested genetic assays and produce a written report; and

WHEREAS, the parties wish to document the scope of testing performed, payment terms, confidentiality obligations and the legal relationship governing the report and related services.

ADMINISTRATIVE INFORMATION

Report Identifier Laboratory

Patient Name:

Patient ID:

Date of Birth:

Ordering Clinician:

SPECIMEN AND TEST DETAILS

Specimen Type: Collection Date: Accession No.:

Test(s) Performed Methodology

RESULTS & INTERPRETATION

Results Summary Interpretation Clinical Indication / Reason for Test Limitations Recommendations

Report Reviewed By:

Report Date:

SCOPE OF WORK

Scope Description

PAYMENT TERMS

Test Fee: Billing Schedule:

Late Payment Fee: . Client is responsible for collection costs and attorneys' fees in the event of default.

TERM AND TERMINATION

Term Start Date: Term End Date:

Termination: Either party may terminate this agreement for convenience upon providing Notice Period (days): days' prior written notice. Termination for material breach may be immediate where the breaching party fails to cure within thirty (30) days following written notice.

CONFIDENTIALITY

Each party shall treat all patient data, test results, proprietary methods, and any non-public information disclosed under this report as confidential. Confidential information shall not be disclosed except (i) as required by law or regulation, (ii) to personnel or contractors bound by confidentiality necessary to perform obligations hereunder, or (iii) with the prior written consent of the disclosing party. The Laboratory will employ commercially reasonable safeguards to protect protected health information in compliance with applicable privacy standards.

GOVERNING LAW

This report and any agreement formed by the issuance of this report shall be governed by and construed in accordance with the laws of the State / Jurisdiction: , without regard to conflicts of law rules.

ENTIRE AGREEMENT

This Genetic Testing Report, together with any expressly incorporated ordering forms and written amendments signed by authorized representatives of both parties, constitutes the entire agreement between the Laboratory and the Client with respect to the testing services described herein and supersedes all prior and contemporaneous agreements and understandings, whether written or oral.

CERTIFICATIONS AND LEGAL NOTICES

The Laboratory certifies that testing was conducted in accordance with its standard operating procedures and applicable quality standards. Results reported are based on the sample received and are valid only for that sample. Results are not a definitive diagnosis and should be interpreted by a qualified clinician in the context of clinical findings and family history. The Laboratory disclaims liability for misuse of results, unauthorized third-party disclosures, or misinterpretation absent Laboratory negligence or willful misconduct.

ADDITIONAL AUTHORIZATIONS

By signing below, the Client and Ordering Clinician acknowledge receipt of this report, confirm authorization of the testing described, accept the payment terms, and agree to the confidentiality and governing law provisions set forth herein.

Client / Ordering Party:

By:

Date:

Laboratory Representative:

By:

Date:

What the Genetic Testing Report Is and when it’s used

A Genetic Testing Report documents the results, methods, and clinical interpretation of laboratory genetic testing performed on a specimen. It summarizes patient identifiers, specimen and test metadata, analytic methods, detected variants or findings, clinical significance, and recommended follow‑up. Reports are used by ordering clinicians, genetic counselors, and authorized recipients to inform diagnosis, treatment, reproductive planning, or research enrollment. Properly assembled reports link each result to chain‑of‑custody, laboratory accreditation (CLIA/CAP), and documented informed consent where required.

Why a standard Genetic Testing Report matters

A clear, complete report supports clinical decision making, meets laboratory accreditation standards, and reduces downstream queries by clinicians and patients. Consistent structure improves data interoperability and legal defensibility when results inform care or are disclosed to third parties.

Primary users and typical recipients

The Genetic Testing Report is completed by clinical laboratories and interpreted by reporting clinicians; it is shared with ordering providers and authorized patients or legal representatives.

Clinical laboratories and medical technologists responsible for test validation and result entry.
Ordering clinicians and genetic counselors who interpret findings for patient care.
Patients, legal guardians, or authorized data recipients who receive results and counseling.

Use controls and access logs to ensure only authorized recipients receive test results; retain audit trails for compliance and continuity of care.

Essential sections to include in a professional report

Organize the report so clinicians can rapidly verify identity, test performed, and a clinically actionable interpretation before following next steps.

Patient Data

Full legal name, date of birth, medical record number, and contact information to ensure accurate attribution of results to the correct individual.

Specimen Details

Specimen type, collection date and time, specimen ID, chain‑of‑custody notes, and any preanalytical remarks that could affect result validity.

Test Information

Assay name, method, gene(s) or region tested, limitations, reference ranges, and laboratory accreditation status (CLIA/CAP).

Results

Observed variants or findings with standardized nomenclature, zygosity, quantitative metrics where applicable, and variant classification.

Interpretation

Clinical significance, recommended follow‑up testing or referrals, and references to evidence or guidelines supporting the interpretation.

Signatures

Reporting laboratory director or authorized signatory name, credentials, signature and date, plus contact information for queries.

Stepwise process to prepare and issue the report

Follow a documented workflow from sample receipt through final sign‑off to maintain traceability and compliance.

01

Receive Specimen: Verify identifiers and log accession number.
02

Perform Analysis: Run assay per validated protocol.
03

Review Results: Clinical scientist reviews analytic and interpretive findings.
04

Authorize Report: Authorized signatory signs and timestamps the final report.

Configuring an online completion workflow

When using a digital platform, set fields, authentication, and routing to mirror laboratory SOPs and privacy controls.

Field	Configuration
Patient Identifier Fields	Require exact match validation and autofill from LIS
Mandatory Review Step	Set reviewer approval before release
Signer Authentication	Use two‑factor or enterprise SSO for authorized signatories
Audit Trail	Enable timestamp, IP, and action logging

Where to file, send, and submit finalized reports

Route reports to the ordering clinician, authorized patient portal, and the laboratory record system according to consent and institutional policy.

Laboratory Information System: Store a signed copy and metadata
Electronic Health Record: Transmit via secure HL7 or secure PDF
Patient Portal: Publish results per consent rules
Public Health Agencies: Report required conditions per law

Digital signing and secure eSubmission considerations

Use a platform that supports audit trails, strong authentication, and HIPAA‑compliant data handling when eSigning or eDelivering reports.

Authentication: Multi‑factor or SSO
Encryption: TLS in transit; AES‑256 at rest
Audit Trail: Timestamps, IP, and action logs

Ensure any eSignature provider can execute a BAA for protected health information, supports secure export formats, and retains forensic audit logs to meet regulatory and accreditation requirements.

Typical timing expectations from collection to delivery

Timelines vary by test complexity; document expected turnaround and any critical notification deadlines in the report metadata.

Specimen Processing Time:

Usually 24–72 hours for single‑gene tests

Panel or Sequencing Turnaround:

Often 7–21 days depending on pipeline

Critical Result Notification:

Immediate phone contact and documented note

Amendment Window:

Correct and reissue as soon as error identified

Patient Portal Release:

Per consent, may be immediate or delayed

Key milestones in report production

A sequential milestone view helps stakeholders track progress from sample receipt to final release.

01

Sample Receipt

Verify identifiers and accession the specimen

02

Analytic Run

Perform laboratory assay and quality checks

03

Interpretive Review

Clinical review and draft interpretation

04

Final Authorization

Authorized signatory approves and timestamps

Common preparation mistakes to avoid

Omitting specimen accession numbers or using inconsistent IDs increases risk of misattribution and requires revalidation.
Using nonstandard variant nomenclature can confuse downstream systems and clinicians; prefer HGVS and standardized classification.
Failing to document assay limitations and sensitivity may lead to inappropriate clinical interpretation or false reassurance.
Not recording informed consent status or disclosure preferences can restrict lawful sharing and create compliance exposure.

Legal and compliance risks if reports are incorrect or mishandled

HIPAA Violation: Potential civil/administrative penalties

CLIA Noncompliance: Fines, corrective actions, suspension

Malpractice Exposure: Clinical harm may trigger liability

Invalid Consent: Limits lawful data disclosure

Sample Mix‑up: Results may be invalidated

Data Breach: Notification and remediation costs

Required identifiers and metadata fields

Patient Name: Full legal name

Date of Birth: MM/DD/YYYY

Specimen ID: Accession or barcode

Test Ordered: Assay name and panel

Ordering Clinician: Name and contact

Consent Status: Documented yes/no and date

Illustrative real‑world scenarios

Two concise examples show how reports are used in clinical and reproductive health settings.

Clinical Genetics Clinic

A pediatric clinic orders a targeted gene panel to evaluate developmental delay

Lab completes sequencing and flags a pathogenic variant for urgent review
The report includes interpretation, recommended referrals, and a signed contact for rapid clinician follow‑up.

Reproductive Medicine Center

A fertility center orders carrier screening for prospective parents

Lab documents results and confirms sample identity through accession numbers
The report is shared with the couple and genetic counselor, with documented consent and recommended next steps.

Sample eSignature vendor comparison for handling Genetic Testing Reports

Comparing basic pricing and capabilities can help choose an eSignature provider that supports HIPAA, audit trails, and enterprise controls.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7‑day free trial, no credit card	Varies	Varies	Yes, limited	Yes, limited
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes (BAA available)	Yes (BAA options)	Yes (BAA options)	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

Frequently asked questions and troubleshooting

Answers to common questions about signing, privacy, and correcting Genetic Testing Reports.

Need help? Contact support

Can a patient eSign the report release?
Yes, electronic consent can be valid if intent, consent, signer attribution, and record retention requirements are met per 15 U.S.C. §7001 and applicable state law; provide a consumer disclosure when required.
Is HIPAA compliance required for eSignature?
Yes for protected health information. Obtain a Business Associate Agreement with the eSignature vendor, enforce access controls, and ensure encryption and audit logging to meet HIPAA obligations (45 CFR §164.504(e)).
What if the report contains an error?
Correct the report promptly, document the reason for amendment and retain the original with an audit trail; reissue the corrected report to all prior recipients and record the correction process.
Are notarization or witnesses necessary?
Typically no for routine clinical reports. Notarization or witnesses may be required for legal uses, certified copies, or jurisdictional evidentiary needs; consult counsel for forensic or court matters.
How to confirm signer identity remotely?
Use multi‑factor authentication, knowledge‑based questions, or enterprise SSO; stronger identity proofing reduces dispute risk and supports auditability during review.
How long must signed reports be kept?
Follow HIPAA retention of 6 years from creation or last effective date (45 CFR §164.530(j)) and retain billing records for at least 3 years per IRS rules (IRC §6501(a)); check state rules for longer requirements.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now